Katsuno, Takayuki
Ozaki, Takenori
Ozeki, Takaya
Hachiya, Asaka
Kim, Hangsoo
Kato, Noritoshi
Ishimoto, Takuji
Kato, Sawako
Kosugi, Tomoki
Tsuboi, Naotake
Mizuno, Masashi
Ito, Yasuhiko
Maruyama, Shoichi
Article History
Received: 16 October 2017
Accepted: 12 May 2018
First Online: 23 May 2018
Compliance with ethical standards
:
: The Department of Nephrology, Nagoya University Graduate School of Medicine received research promotion grants from Otsuka Pharmaceutical Co, Kissei Pharmaceutical Co, Novartis Pharma K.K, Kowa Pharmaceutical Co, Chugai Pharmaceutical Co, Nippon Boehringer Ingelheim Co ., Ltd, Pfizer Japan Inc, Kyowa Hakko Kirin Co ., Ltd, Torii Pharmaceutical Co.,Ltd, Astellas Pharma Inc, MSD K.K, Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma Corporation, Sumitomo Dainippon Pharma Co., Ltd, Teijin Pharma Limited, and Mochida Pharmaceutical Co ., Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB Approval Number 2017-0086) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The ethical committee approved this retrospective cohort study without written informed consent, but informed consent was obtained from most patients at the time of renal biopsy.